Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,513 | 17 | 1,871 | 1,866 | 9,142 |
| TOTAL | $1,556 | $304 | $2,591 | $3,130 | $9,628 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,556 | $304 | $2,591 | $3,130 | $9,628 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,469 | 2,356 | 2,885 | 1,844 | 1,694 |
| Other current liabilities | N/A | N/A | 2,500 | 2,500 | 6,000 |
| TOTAL | $2,469 | $2,356 | $5,385 | $4,344 | $7,694 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,469 | $2,356 | $5,385 | $4,344 | $7,694 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,063 | 196 | 196 | 47 | 47 |
| Retained earnings | -71,611 | -68,221 | -66,215 | -62,765 | -59,544 |
| TOTAL | $-914 | $-2,052 | $-2,795 | $-1,213 | $1,934 |
| Total Liabilities And Equity | $1,556 | $304 | $2,591 | $3,130 | $9,628 |